(S,R,S)-AHPC-PEG6-Alkyne is an advanced E3 Ligase Ligand-Linker Conjugate designed for PROTAC (Proteolysis Targeting Chimera) drug discovery research. This molecule features the high-affinity VHL (Von Hippel-Lindau) E3 ligase ligand (AHPC) linked via a flexible PEG6 spacer, terminated with an alkyne functional group for bioorthogonal conjugation using click chemistry. As a key component in the synthesis of bifunctional PROTACs, (S,R,S)-AHPC-PEG6-Alkyne enables efficient recruitment of the VHL E3 ubiquitin ligase to target proteins of interest, promoting their selective ubiquitination and proteasomal degradation. This product is particularly valuable for developing and optimizing next-generation targeted protein degraders, offering versatile applications in oncology, neurodegenerative disease research, and tool compound development. With its optimized linker length and modular design, (S,R,S)-AHPC-PEG6-Alkyne facilitates flexible coupling to diverse ligands for target proteins, making it the preferred choice for innovative PROTAC synthesis and chemical biology investigations.
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(S,R,S)-AHPC-PEG6-Alkyne is a versatile E3 ligase ligand-linker conjugate designed for advanced protein degradation technologies, notably PROTACs (Proteolysis Targeting Chimeras). It incorporates (S,R,S)-AHPC, a high-affinity ligand for the von Hippel-Lindau (VHL) E3 ubiquitin ligase complex, connected via a PEG6 (polyethylene glycol, 6 units) linker to an alkyne functional group. This flexible and reactive scaffold is ideal for chemical conjugation, enabling the development of novel PROTAC molecules targeting disease-relevant proteins.
Mechanism
(S,R,S)-AHPC-PEG6-Alkyne functions by leveraging the body's ubiquitin-proteasome system. The (S,R,S)-AHPC moiety selectively recruits the VHL E3 ligase complex, while the PEG6 linker provides an optimal spatial arrangement for target engagement. The alkyne group allows for bioorthogonal 'click chemistry', enabling attachment to a variety of target protein ligands or small molecules. Once the conjugate brings the E3 ligase and the protein of interest into proximity, ubiquitination is triggered, leading to proteasomal degradation of the target protein.
Applications
This E3 ligase ligand-linker conjugate is primarily utilized in the synthesis of custom PROTACs for target protein degradation. Its alkyne handle enables modular assembly with azide-functionalized compounds via copper-catalyzed azide-alkyne cycloaddition (CuAAC). Researchers employ (S,R,S)-AHPC-PEG6-Alkyne for structure-activity relationship (SAR) studies, target validation, and therapeutic discovery in oncology, neurodegeneration, and immunology. This product supports rapid prototyping and optimization of bifunctional degraders for both in vitro and in vivo applications.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.